CN112110864B - 一种4-酰胺取代嘧啶类靶向ddr1抑制剂及其制备和抗肿瘤活性的应用 - Google Patents
一种4-酰胺取代嘧啶类靶向ddr1抑制剂及其制备和抗肿瘤活性的应用 Download PDFInfo
- Publication number
- CN112110864B CN112110864B CN202010576531.0A CN202010576531A CN112110864B CN 112110864 B CN112110864 B CN 112110864B CN 202010576531 A CN202010576531 A CN 202010576531A CN 112110864 B CN112110864 B CN 112110864B
- Authority
- CN
- China
- Prior art keywords
- ddr1
- cells
- chloro
- substituted
- dmso
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
编号 | 抑制率(%) | 编号 | 抑制率(%) | 编号 | 抑制率(%) |
C4 | 17.7 | C14 | 15.2 | C24 | 15.5 |
C5 | 46 | C15 | 4.4 | C25 | 24.8 |
C6 | 28.2 | C16 | 4.4 | C26 | 3.3 |
C7 | 6.3 | C17 | 5 | C27 | 31.9 |
C8 | 15.5 | C18 | 0.1 | C28 | 22.5 |
C9 | 22.3 | C19 | 43.3 | C29 | 9.7 |
C10 | 12.4 | C20 | 18.9 | Yfq07 | 26 |
C11 | 25.2 | C21 | -7.1 | C1 | 92.2 |
C12 | 21.9 | C22 | -0.1 | C2 | 4.4 |
C13 | 13.7 | C23 | -8 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010576531.0A CN112110864B (zh) | 2020-06-22 | 2020-06-22 | 一种4-酰胺取代嘧啶类靶向ddr1抑制剂及其制备和抗肿瘤活性的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010576531.0A CN112110864B (zh) | 2020-06-22 | 2020-06-22 | 一种4-酰胺取代嘧啶类靶向ddr1抑制剂及其制备和抗肿瘤活性的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112110864A CN112110864A (zh) | 2020-12-22 |
CN112110864B true CN112110864B (zh) | 2022-07-22 |
Family
ID=73799639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010576531.0A Active CN112110864B (zh) | 2020-06-22 | 2020-06-22 | 一种4-酰胺取代嘧啶类靶向ddr1抑制剂及其制备和抗肿瘤活性的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112110864B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113956234B (zh) * | 2021-10-27 | 2023-07-21 | 温州医科大学 | 一种n-苯基取代1h-吲唑-3-胺类化合物及其制备和抗肿瘤活性的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ547517A (en) * | 2004-02-27 | 2009-04-30 | Eisai R&D Man Co Ltd | Novel pyridine and pyrimidine derivatives for hepatocyte growth and tumour inihibition |
CN108368060B (zh) * | 2017-12-21 | 2020-09-15 | 中国科学院合肥物质科学研究院 | 一类嘧啶类衍生物激酶抑制剂 |
CN109053593B (zh) * | 2018-08-07 | 2020-12-04 | 温州医科大学 | 1-(2,6-氯苯基)-3-(取代嘧啶-4-基)脲类化合物及其制备和应用 |
CN110563657B (zh) * | 2019-07-05 | 2024-05-03 | 温州医科大学 | 一种1-(2,6-二氯苯基)-3-取代脲类结肠癌抑制剂及其制备和应用 |
-
2020
- 2020-06-22 CN CN202010576531.0A patent/CN112110864B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112110864A (zh) | 2020-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104292170B (zh) | 具有抗肿瘤作用的喹唑啉-芳基脲衍生物及其应用 | |
EP1870414A1 (en) | Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency | |
EP2896620A1 (en) | Alkynyl heteroaromatic ring compound and application thereof | |
EP3312180A1 (en) | Use of pteridinone derivative serving as egfr inhibitor | |
CN104367575B (zh) | 一种Bouchardatine和Bouchardatine衍生物及其制备方法和应用 | |
CN108101926B (zh) | 含喹啉酮的嘧啶并五元杂环类化合物、制备方法及其应用 | |
CN105705493A (zh) | 喹唑啉衍生物、其制备方法、药物组合物和应用 | |
CN112110864B (zh) | 一种4-酰胺取代嘧啶类靶向ddr1抑制剂及其制备和抗肿瘤活性的应用 | |
Mularski et al. | The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline series | |
CN116987066A (zh) | 一种嘧啶类化合物及其制备方法和应用 | |
RU2468022C2 (ru) | Производные дигидроиндолона | |
CN107721975A (zh) | 具有抗肿瘤活性的brd4小分子抑制剂、合成方法及其应用 | |
CN109320473A (zh) | 噻唑氨基苯甲酰胺乙酸衍生物及其用途 | |
CN109053592A (zh) | 1-(2,5-二甲氧基苯基)-3-(取代嘧啶-4-基)脲类化合物及其制备和应用 | |
CN109053593A (zh) | 1-(2,6-氯苯基)-3-(取代嘧啶-4-基)脲类化合物及其制备和应用 | |
CN110357852B (zh) | 苯并嘧啶类化合物、制备方法和用途 | |
CN115466245B (zh) | 一种嘧啶联吡啶的异羟肟酸类衍生物及其制备方法与应用 | |
CN113583007B (zh) | 一种吡咯并嘧啶类btk抑制剂及其制备方法与应用 | |
CN109456279A (zh) | 噻唑氨基苯甲酰胺乙酸酯衍生物及其用途 | |
CN111777562B (zh) | 一种6-苯氧基取代嘧啶类靶向ddr1抑制剂及其制备和抗肿瘤活性的应用 | |
CN109053594A (zh) | 1-(3,5-二甲氧基苯基)-3-(取代嘧啶-4-基)脲类化合物及其制备和应用 | |
KR101789934B1 (ko) | 상피세포성장인자수용체 변이체를 가진 종양 진단 및 종양 성장 억제 활성을 갖는 신규 화합물 및 이를 포함하는 의학적 용도 | |
CN114805304A (zh) | 一类含1-甲基-1h-吲哚结构的4-甲氧基苯基-1,3-二胺衍生物及其应用 | |
WO2014071824A1 (zh) | 4-氨基喹唑啉杂环化合物及其用途 | |
CN110256465A (zh) | 一种含二氢吡喃并噻唑的2,4-二氨基嘧啶及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Xuebao Inventor after: Chen Bo Inventor after: Ye Faqing Inventor after: Du Zongxuan Inventor after: Yang Xiaojiao Inventor after: Qian Jinheng Inventor after: Tu Sijun Inventor after: Xie Zixin Inventor after: Zhang Yuan Inventor before: Ye Faqing Inventor before: Chen Bo Inventor before: Du Zongxuan Inventor before: Yang Xiaojiao Inventor before: Qian Jinheng Inventor before: Tu Sijun Inventor before: Xie Zixin Inventor before: Zhang Yuan Inventor before: Wang Xuebao |
|
GR01 | Patent grant | ||
GR01 | Patent grant |